Literature DB >> 26269517

Development and validation of patient-reported outcomes scale for hypertension.

Li Zhi1, Liu Qiaojun1, Zhang Yanbo1.   

Abstract

OBJECTIVE: To validate a patient-reported outcomes (PROs) measure for patients with hypertension.
DESIGN: This was a validation study that employed mixed methods including classical test theory, item response theory, and reliability and validity evaluation.
SETTING: The community health centers in two Chinese cities. PARTICIPANTS: Fifteen patients participated in the pilot survey, and 641 patients completed the PRO survey. MAIN OUTCOME MEASURES: Classical test theory and item response theory were applied to the item selection. Evaluations and adjustments were based on results of reliability, validity, responsiveness and feasibility analyses.
RESULTS: The item selection process produced a final scale with 4 domains (physiology, psychology, society and treatment), 12 subdomains and 56 items. According to confirmatory factor analysis, the construct validity was adequate. The split-half reliability, Cronbach's α coefficients and responsiveness both in each subdomain and in the whole scale were also acceptable, as was feasibility.
CONCLUSIONS: Mixed methods were beneficial for developing this scale and could be applied to PROs in other health areas. The instrument provides a means for comprehensive assessment of the impact of hypertension, and for quantification of benefits of hypertension interventions from the patients' perspective.
© The Author 2015. Published by Oxford University Press in association with the International Society for Quality in Health Care; all rights reserved.

Entities:  

Keywords:  classical test theory; confirmatory factor analysis; hypertension; item response theory; patient-reported outcomes

Mesh:

Year:  2015        PMID: 26269517     DOI: 10.1093/intqhc/mzv060

Source DB:  PubMed          Journal:  Int J Qual Health Care        ISSN: 1353-4505            Impact factor:   2.038


  4 in total

1.  Health protective behavior scale: Development and psychometric evaluation.

Authors:  Weiwei Ping; Wenjun Cao; Hongzhuan Tan; Chongzheng Guo; Zhiyong Dou; Jianzhou Yang
Journal:  PLoS One       Date:  2018-01-08       Impact factor: 3.240

2.  Stage 1 development of a patient-reported experience measure (PREM) for chronic obstructive pulmonary disease (COPD).

Authors:  Susan Walker; Sharon Andrew; Matthew Hodson; C Michael Roberts
Journal:  NPJ Prim Care Respir Med       Date:  2017-07-24       Impact factor: 2.871

3.  BC-PROM: validation of a patient-reported outcomes measure for patients with breast cancer.

Authors:  Xiaojuan Hu; Chunsen Zhang; Yanbo Zhang
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

4.  Validation of the Weight Bias Internalization Scale for Mainland Chinese Children and Adolescents.

Authors:  Hao Chen; Yi-Duo Ye
Journal:  Front Psychol       Date:  2021-01-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.